PHARMAZEUTISCHE PEPTIDE FORMULIERUNGEN ZUR BEHANDLUNG VON STAUBMILBEN ALLERGIE

The present invention provides novel therapeutic compositions and multipeptide formulations of peptides and modified peptides of Group I and Group II Der p and Der f derived protein allergens. Such novel therapeutic compositions and multipeptide formulations are the result of a preformulation scheme to develop an optimized drug product for therapeutic treatment of humans suffering from allergy to house dust mite allergens. The Der p and Der f peptides and modified peptides in accordance with the invention possess certain unique characteristics which render them particularly suitable for drug product formulation. Therapeutic compositions and multipeptide formulations of the invention have been optimized to accommodate and maintain the unique characteristics of the peptides and modified peptides derived from house dust mite protein allergens and at the same time provide maximum therapeutic effect when used in therapeutic regimens for the treatment of house dust mite allergy in humans. The invention further provides novel modified peptides derived from Der p I and Der p II protein allergens.